Green Fresh Biotechnology Company Limited (HKG:1084)
Hong Kong · Delayed Price · Currency is HKD 0.6600
0.00 (0.00%)
May 29, 2026, 3:53 PM HKT
HKG:1084 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 904.69 | 989.26 | 1,174 | 1,411 | 947.58 | |
Revenue Growth (YoY) | -8.55% | -15.74% | -16.79% | 48.89% | 28.29% |
Cost of Revenue | 737.47 | 766.8 | 1,136 | 1,027 | 727.27 |
Gross Profit | 167.23 | 222.46 | 37.64 | 384.12 | 220.31 |
Selling, General & Admin | 136.44 | 125.21 | 115.12 | 104.91 | 89.15 |
Other Operating Expenses | -6.8 | -11.37 | -4.43 | -9.62 | -6.68 |
Operating Expenses | 130.94 | 114.82 | 107.52 | 95.66 | 82.47 |
Operating Income | 36.28 | 107.64 | -69.88 | 288.46 | 137.85 |
Interest Expense | -27.3 | -29.88 | -37.38 | -25.64 | -17.08 |
Interest & Investment Income | 0.29 | 0.69 | 0.4 | 0.13 | 0.16 |
Currency Exchange Gain (Loss) | -1.76 | 2.53 | -5.85 | -1.3 | -2.19 |
EBT Excluding Unusual Items | 7.51 | 80.97 | -112.71 | 261.65 | 118.74 |
Gain (Loss) on Sale of Investments | - | - | - | 0.11 | -2.77 |
Gain (Loss) on Sale of Assets | -0.38 | -0.1 | -0.18 | -0.17 | -0.92 |
Asset Writedown | - | - | - | - | -2.93 |
Pretax Income | 7.12 | 80.87 | -112.89 | 261.59 | 112.12 |
Income Tax Expense | 1.75 | 20 | -27.45 | 61.67 | 27.45 |
Earnings From Continuing Operations | 5.37 | 60.88 | -85.44 | 199.92 | 84.67 |
Minority Interest in Earnings | 1.22 | 1.29 | 0.12 | -0.69 | -0.25 |
Net Income | 6.59 | 62.17 | -85.33 | 199.23 | 84.42 |
Net Income to Common | 6.59 | 62.17 | -85.33 | 199.23 | 84.42 |
Net Income Growth | -89.40% | - | - | 136.00% | 45.50% |
Shares Outstanding (Basic) | 863 | 836 | 828 | 823 | 819 |
Shares Outstanding (Diluted) | 863 | 838 | 828 | 831 | 841 |
Shares Change (YoY) | 3.08% | 1.19% | -0.43% | -1.14% | 2.34% |
EPS (Basic) | 0.01 | 0.07 | -0.10 | 0.24 | 0.10 |
EPS (Diluted) | 0.01 | 0.07 | -0.10 | 0.24 | 0.10 |
EPS Growth | -89.69% | - | - | 139.51% | 41.67% |
Free Cash Flow | -18.78 | 82.49 | 84.75 | -69.39 | 7.16 |
Free Cash Flow Per Share | -0.02 | 0.10 | 0.10 | -0.08 | 0.01 |
Dividend Per Share | 0.011 | 0.011 | - | 0.044 | 0.033 |
Dividend Growth | -4.36% | - | - | 35.72% | -22.60% |
Gross Margin | 18.48% | 22.49% | 3.21% | 27.23% | 23.25% |
Operating Margin | 4.01% | 10.88% | -5.95% | 20.45% | 14.55% |
Profit Margin | 0.73% | 6.29% | -7.27% | 14.12% | 8.91% |
Free Cash Flow Margin | -2.08% | 8.34% | 7.22% | -4.92% | 0.76% |
EBITDA | 80.89 | 152.67 | -26.06 | 335.06 | 177.72 |
EBITDA Margin | 8.94% | 15.43% | -2.22% | 23.75% | 18.75% |
D&A For EBITDA | 44.61 | 45.03 | 43.82 | 46.6 | 39.88 |
EBIT | 36.28 | 107.64 | -69.88 | 288.46 | 137.85 |
EBIT Margin | 4.01% | 10.88% | -5.95% | 20.45% | 14.55% |
Effective Tax Rate | 24.62% | 24.73% | - | 23.57% | 24.49% |
Advertising Expenses | 3.81 | 3.09 | 2.6 | 2.19 | - |